Clinical data | |
---|---|
Trade names | Diabinese |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682479 |
License data |
|
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | >90% |
Protein binding | 90% |
Metabolism | <1% |
Elimination half-life | 36 hours |
Excretion | Renal (glomerular filtration → reabsorption → tubular secretion) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.002.104 |
Chemical and physical data | |
Formula | C10H13ClN2O3S |
Molar mass | 276.74 g·mol−1 |
3D model (JSmol) | |
Melting point | 126 to 130 °C (259 to 266 °F) |
| |
| |
(verify) |
Chlorpropamide is an antidiabetic drug, belonging to the sulfonylurea class of organic compounds. It is used to treat diabetes mellitus type 2. It is a long-acting first-generation sulfonylurea.